Europe Stroke Market
Description
The Europe stroke market is expected to reach USD 16.55 billion by 2032 from USD 9.72 billion in 2024, growing at a substantial CAGR of 7.2 % in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Stroke Market, By Type (Ischemic Stroke, Hemorrhage Stroke, and Transient Ischemic Attack (TIA)), Diagnosis & Treatment (Treatment and Diagnosis), Gender (Female and Male), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, Laboratories, and Others), Distribution Channel (Direct, Retail, and Online), Country (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Ireland, Norway, Poland, and rest of Europe) - Industry Trends & Forecast To 2032
Overview of the Europe Stroke Market Dynamics:
Drivers
• Rising incidences of stroke drive demand for treatments
• Increasing number of patients with hypertension and coronary heart diseases
Restraints
• High cost of diagnosis
• Increase in product recalls
Opportunities
• High cost of diagnosis
• Increase in product recalls
Market Players:
The key market players for Europe stroke market are listed below:
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• F. Hoffmann-La Roche Ltd
• DAIICHI SANKYO COMPANY, LIMITED
• Sanofi
• Johnson & Johnson Services, Inc.
• Bayer AG
• Sandoz AG
• Pfizer Inc.
• Medtronic
• Abbott
• Viatris Inc.
• AstraZeneca
• Penumbra, Inc.
• GLENMARK PHARMACEUTICALS LTD
• Fresenius SE & Co. KGaA
• Teva Pharmaceuticals USA, Inc.
• Lupin
• Amneal Pharmaceuticals LLC
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Market Segmentation:
Europe Stroke Market, By Type (Ischemic Stroke, Hemorrhage Stroke, and Transient Ischemic Attack (TIA)), Diagnosis & Treatment (Treatment and Diagnosis), Gender (Female and Male), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, Laboratories, and Others), Distribution Channel (Direct, Retail, and Online), Country (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Ireland, Norway, Poland, and rest of Europe) - Industry Trends & Forecast To 2032
Overview of the Europe Stroke Market Dynamics:
Drivers
• Rising incidences of stroke drive demand for treatments
• Increasing number of patients with hypertension and coronary heart diseases
Restraints
• High cost of diagnosis
• Increase in product recalls
Opportunities
• High cost of diagnosis
• Increase in product recalls
Market Players:
The key market players for Europe stroke market are listed below:
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• F. Hoffmann-La Roche Ltd
• DAIICHI SANKYO COMPANY, LIMITED
• Sanofi
• Johnson & Johnson Services, Inc.
• Bayer AG
• Sandoz AG
• Pfizer Inc.
• Medtronic
• Abbott
• Viatris Inc.
• AstraZeneca
• Penumbra, Inc.
• GLENMARK PHARMACEUTICALS LTD
• Fresenius SE & Co. KGaA
• Teva Pharmaceuticals USA, Inc.
• Lupin
• Amneal Pharmaceuticals LLC
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
350 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Limitations
- 1.4 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 5 Europe Stroke Market, Regulatory Framework
- 5.1 Regulation In U.S.
- 5.2 Regulation In Europe
- 5.3 Regulation In China
- 5.4 Regulation In Japan
- 5.5 Regulation In South Africa
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Incidences Of Stroke Drive Demand For Treatments
- 6.1.2 Increasing Number Of Patients With Hypertension And Coronary Heart Diseases
- 6.1.3 Increasing Diabetic And Obese Populations Elevate Stroke Risks
- 6.1.4 Advancements In Medical Technology Improve Stroke Care Outco.Mes
- 6.2 Restraints
- 6.2.1 High Cost Of Diagnosis
- 6.2.2 Increase In Product Recall
- 6.3 Opportunities
- 6.3.1 Development Of Advanced Therapeutics For Strokes
- 6.3.2 Expansion In Stroke Rehabilitation Services
- 6.3.3 Innovative Treatments In Pipeline For Stroke Treatment
- 6.4 Challenges
- 6.4.1 False Diagnosis In Strokes
- 6.4.2 Complications Associated With Managing Stroke
- 7 Europe Stroke Market, By Type
- 7.1 Overview
- 7.2 Ischemic Stroke
- 7.2.1 Thrombotic (Cerebral Thrombosis)
- 7.2.2 Embolic (Cerebral Embolism)
- 7.3 Hemorrhagic Stroke
- 7.3.1 Subarachnoid Hemorrhage
- 7.3.2 Intracerebral Hemorrhage
- 7.4 Transient Ischemic Attact (Tia)
- 8 Europe Stroke Market, By Gender
- 8.1 Overview
- 8.2 Female
- 8.3 Male
- 9 Europe Stroke Market, By Diagnosis And Treatment
- 9.1 Overview
- 9.2 Treatment
- 9.2.1 By Treatment Type
- 9.2.1.1 Medication
- 9.2.1.1.1 Medication, By Class
- 9.2.1.1.1.1 Blood Pressure Medicines
- 9.2.1.1.1.1.1 Angiotensin-converting Enzyme (Ace) Inhibitors
- 9.2.1.1.1.1.2 Ramipril
- 9.2.1.1.1.1.3 Lisinopril
- 9.2.1.1.1.1.4 Enalapril
- 9.2.1.1.1.1.5 Perindopril
- 9.2.1.1.1.1.6 Other
- 9.2.1.1.1.2 Thiazide Diuretics
- 9.2.1.1.1.2.1 Indapamide
- 9.2.1.1.1.2.2 Bendroflumethiazide
- 9.2.1.1.1.2.3 Spironolactone
- 9.2.1.1.1.2.4 Amiloride
- 9.2.1.1.1.2.5 Other
- 9.2.1.1.1.3 Calcium Channel Blockers
- 9.2.1.1.1.3.1 Amlodipine
- 9.2.1.1.1.3.2 Nifedipine
- 9.2.1.1.1.3.3 Verapamil
- 9.2.1.1.1.3.4 Nicardipine
- 9.2.1.1.1.3.5 Felodipine
- 9.2.1.1.1.3.6 Nimodipine
- 9.2.1.1.1.3.7 Others
- 9.2.1.1.1.4 Beta Blockers
- 9.2.1.1.1.4.1 Atenolol
- 9.2.1.1.1.4.2 Bisoprolol
- 9.2.1.1.1.4.3 Labetolol
- 9.2.1.1.1.4.4 Others
- 9.2.1.1.1.5 Alpha-blockers
- 9.2.1.1.1.5.1 Doxazosin
- 9.2.1.1.1.5.2 Others
- 9.2.1.1.1.6 Others
- 9.2.1.1.1.7 Antiplatelet Drugs
- 9.2.1.1.1.7.1 Aspirin
- 9.2.1.1.1.7.2 Clopidogrel
- 9.2.1.1.1.7.3 Dipyridamole
- 9.2.1.1.1.7.4 Ticlopidine
- 9.2.1.1.1.7.5 Others
- 9.2.1.1.1.8 Anticoagulants
- 9.2.1.1.1.8.1 Warfarin
- 9.2.1.1.1.8.2 Apixaban
- 9.2.1.1.1.8.3 Dabigatran
- 9.2.1.1.1.8.4 Heparin
- 9.2.1.1.1.8.5 Rivaroxaban
- 9.2.1.1.1.8.6 Others
- 9.2.1.1.1.9 Tissue Plasminogen Activator (Tpa)
- 9.2.1.1.1.9.1 Alteplase
- 9.2.1.1.1.9.2 Tenecteplase
- 9.2.1.1.1.9.3 Reteplase
- 9.2.1.1.1.9.4 Anistreplase
- 9.2.1.1.1.9.5 Others
- 9.2.1.1.1.10 Statins
- 9.2.1.1.1.10.1.1 Atorvastatin
- 9.2.1.1.1.10.1.2 Simvastatin
- 9.2.1.1.1.10.1.3 Lovastatin
- 9.2.1.1.1.10.1.4 Rosuvastatin
- 9.2.1.1.1.10.1.5 Fluvastatin
- 9.2.1.1.1.10.1.6 Pravastatin
- 9.2.1.1.1.10.1.7 Pitavastatin
- 9.2.1.1.1.10.1.8 Others
- 9.2.1.1.1.11 Vitamin K
- 9.2.1.1.1.12 Supportive Medication
- 9.2.1.1.1.12.1 Nutritional Supplements
- 9.2.1.1.1.12.2 Antipyretics
- 9.2.1.1.1.12.3 Others
- 9.2.1.1.2 Medication, By Drug Type
- 9.2.1.1.2.1 Branded
- 9.2.1.1.2.1.1 Activase
- 9.2.1.1.2.1.2 Edobaxan
- 9.2.1.1.2.1.3 Coumadin
- 9.2.1.1.2.1.4 Heparin Leo
- 9.2.1.1.2.1.5 Duoplavin
- 9.2.1.1.2.1.6 Aggrenox
- 9.2.1.1.2.1.7 Retavase
- 9.2.1.1.2.1.8 Jantoven
- 9.2.1.1.2.1.9 Cathflo
- 9.2.1.1.2.1.10 Other
- 9.2.1.1.2.2 Generic
- 9.2.1.1.3 Medication, By Route Of Administration
- 9.2.1.1.3.1 Oral
- 9.2.1.1.3.1.1 Tablet
- 9.2.1.1.3.1.2 Capsules
- 9.2.1.1.3.1.3 Others
- 9.2.1.1.3.2 Parenteral
- 9.2.1.1.3.2.1 Intravenous
- 9.2.1.1.3.2.2 Subcutaneous
- 9.2.1.1.3.3 Others
- 9.2.1.1.4 Medication, By Mode Of Purchase
- 9.2.1.1.4.1 Prescription
- 9.2.1.1.4.2 Over The Counter (Otc)
- 9.2.1.1.5 Medication, By Therapy Type
- 9.2.1.1.5.1 Combination Therapy
- 9.2.1.1.5.2 Monotherapy
- 9.2.1.2 Surgery
- 9.2.1.2.1 Embolic Coils
- 9.2.1.2.2 Aspiration Catheters
- 9.2.1.2.3 Stent Retriever
- 9.2.1.2.4 Surgical Clipping
- 9.2.1.2.5 Others
- 9.2.1.3 Others Therapy
- 9.2.1.3.1 Physical Therapy
- 9.2.1.3.2 Occupational Therapy
- 9.2.1.3.3 Speech Therapy
- 9.2.1.3.4 Others
- 9.3 Diagnosis
- 9.3.1 Imaging Test
- 9.3.1.1 Computerized Tomography (Ct) Scan
- 9.3.1.2 Magnetic Resonance Imaging (Mri)
- 9.3.1.3 Carotid Ultrasound
- 9.3.1.4 Cerebral Angiogram
- 9.3.2 Blood Test
- 9.3.3 Echocardiogram
- 9.3.4 Lumbar Puncture
- 9.3.5 Others
- 10 Europe Stroke Market, By Distribution Channel
- 10.1 Overview
- 10.2 Direct
- 10.3 Retail
- 10.4 Online
- 11 Europe Stroke Market, By End User
- 11.1 Overview
- 11.2 Hospitals & Clinics
- 11.3 Specialty Clinics
- 11.4 Ambulatory Surgical Center
- 11.5 Homecare
- 11.6 Laboratories
- 11.7 Others
- 12 Europe Stroke Market, By Region
- 12.1 Europe
- 12.1.1 Germany
- 12.1.2 U.K.
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Russia
- 12.1.7 Netherlands
- 12.1.8 Switzerland
- 12.1.9 Turkey
- 12.1.10 Austria
- 12.1.11 Poland
- 12.1.12 Norway
- 12.1.13 Ireland
- 12.1.14 Rest Of Europe
- 13 Europe Stroke Market, Company Landscape
- 13.1 Company Share Analysis: Europe
- 14 Swot Analysis
- 15 Company Profiles
- 15.1 Bristol-myers Squibb Company
- 15.1.1 Company Snapshot
- 15.1.2 Revenue Analysis
- 15.1.3 Company Share Analysis
- 15.1.4 Product Portfolio
- 15.2 F. Hoffmann-la Roche Ltd
- 15.2.1 Company Snapshot
- 15.2.2 Revenue Analysis
- 15.2.3 Company Share Analysis
- 15.2.4 Product Portfolio
- 15.2.5 Recent Development
- 15.3 Boehringer Ingelheim International Gmbh
- 15.3.1 Company Snapshot
- 15.3.2 Company Share Analysis
- 15.3.3 Product Portfolio
- 15.3.4 Recent Development
- 15.4 Daiichi Sankyo Company, Limited
- 15.4.1 Company Snapshot
- 15.4.2 Revenue Analysis
- 15.4.3 Company Share Analysis
- 15.4.4 Product Portfolio
- 15.4.5 Recent Development
- 15.5 Sanofi
- 15.5.1 Company Snapshot
- 15.5.2 Revenue Analysis
- 15.5.3 Company Share Analysis
- 15.5.4 Product Portfolio
- 15.6 Abbott
- 15.6.1 Company Snapshot
- 15.6.2 Revenue Analysis
- 15.6.3 Product Portfolio
- 15.6.4 Recent Development
- 15.7 Amneal Pharmaceuticals Llc
- 15.7.1 Company Snapshot
- 15.7.2 Revenue Analysis
- 15.7.3 Product Portfolio
- 15.7.4 Recent Development
- 15.8 Astrazeneca
- 15.8.1 Company Snapshot
- 15.8.2 Revenue Analysis
- 15.8.3 Product Portfolio
- 15.8.4 Recent Development
- 15.9 Bayer Ag
- 15.9.1 Company Snapshot
- 15.9.2 Revenue Analysis
- 15.9.3 Product Portfolio
- 15.9.4 Recent Development
- 15.10 Fresenius Se & Co. Kgaa
- 15.10.1 Company Snapshot
- 15.10.2 Revenue Analysis
- 15.10.3 Product Portfolio
- 15.10.4 Recent Development
- 15.11 Glenmark Pharmaceuticals Ltd.
- 15.11.1 Company Snapshot
- 15.11.2 Revenue Analysis
- 15.11.3 Product Portfolio
- 15.11.4 Recent Development
- 15.12 Johnson & Johnson Services, Inc.
- 15.12.1 Company Snapshot
- 15.12.2 Revenue Analysis
- 15.12.3 Product Portfolio
- 15.12.4 Recent Development
- 15.13 Lupin
- 15.13.1 Company Snapshot
- 15.13.2 Revenue Analysis
- 15.13.3 Product Portfolio
- 15.13.4 Recent Development
- 15.14 Medtronic
- 15.14.1 Company Snapshot
- 15.14.2 Revenue Analysis
- 15.14.3 Product Portfolio
- 15.14.4 Recent Development
- 15.15 Penumbra, Inc.
- 15.15.1 Company Snapshot
- 15.15.2 Revenue Analysis
- 15.15.3 Product Portfolio
- 15.15.4 Recent Development
- 15.16 Pfizer Inc.
- 15.16.1 Company Snapshot
- 15.16.2 Revenue Analysis
- 15.16.3 Product Portfolio
- 15.16.4 Recent Development
- 15.17 Sandoz Ag
- 15.17.1 Company Snapshot
- 15.17.2 Revenue Analysis
- 15.17.3 Product Portfolio
- 15.17.4 Recent Development
- 15.18 Teva Pharmaceuticals Usa, Inc.
- 15.18.1 Company Snapshot
- 15.18.2 Revenue Analysis
- 15.18.3 Product Portfolio
- 15.18.4 Recent Development
- 15.19 Viatris Inc.
- 15.19.1 Company Snapshot
- 15.19.2 Revenue Analysis
- 15.19.3 Product Portfolio
- 15.19.4 Recent Development
- 16 Questionnaire
- 17 Related Reports
- List Of Tables
- Table 1 Europe Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 2 Europe Ischemic Stroke In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 3 Europe Ischemic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 4 Europe Hemorrhagic Stroke In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 5 Europe Hemorrhagic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 6 Europe Transient Ischemic Attact (Tia) In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 7 Europe Stroke Market, By Gender, 2018-2032 (Usd Thousand)
- Table 8 Europe Female In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 9 Europe Male In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 10 Europe Stroke Market, By Diagnosis And Treatment, 2018-2032 (Usd Thousand)
- Table 11 Europe Treatment In Stroke Market, By Region, 2018-2032 (Usd Thousand)..
- Table 12 Europe Treatment In Stroke Market, By Treatment Type, 2018-2032 (Usd Thousand)
- Table 13 Europe Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)..
- Table 14 Europe Blood Pressure Medicines In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 15 Europe Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 16 Europe Thiazide Diuretics In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 17 Europe Calcium Channel Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 18 Europe Beta Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 19 Europe Alpha-blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 20 Europe Antiplatelet Drugs In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 21 Europe Anticoagulants In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 22 Europe Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 23 Europe Statins In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 24 Europe Supportive Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 25 Europe Medication In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)
- Table 26 Europe Branded In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)
- Table 27 Europe Medication In Stroke Market, By Route Of Administration, 2018-2032 (Usd Thousand)
- Table 28 Europe Oral In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 29 Europe Parenteral In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 30 Europe Medication In Stroke Market, By Mode Of Purchase, 2018-2032 (Usd Thousand)
- Table 31 Europe Medication In Stroke Market, By Therapy Type, 2018-2032 (Usd Thousand)
- Table 32 Europe Surgery In Stroke Market, By Instrument Type, 2018-2032 (Usd Thousand)
- Table 33 Europe Other Therapy In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 34 Europe Diagnosis In Stroke Market, By Region, 2018-2032 (Usd Thousand)…
- Table 35 Europe Diagnosis In Stroke Market, By Diagnosis Type, 2018-2032 (Usd Thousand)
- Table 36 Europe Imaging Test In Stroke Market, By Type, 2018-2032 (Usd Thousand)…
- Table 37 Europe Stroke Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 38 Europe Direct In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 39 Europe Retail In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 40 Europe Online In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 41 Europe Stroke Market, By End User, 2018-2032 (Usd Thousand)
- Table 42 Europe Hospitals & Clinics In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 43 Europe Specialty Clinics In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 44 Europe Ambulatory Surgical Center In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 45 Europe Homecare In Stroke Market, By Region, 2018-2032 (Usd Thousand)..
- Table 46 Europe Laboratories In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 47 Europe Others In Stroke Market, By Region, 2018-2032 (Usd Thousand)
- Table 48 Europe Stroke Market, By Country, 2018-2032 (Usd Thousand)
- Table 49 Europe Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 50 Europe Ischemic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 51 Europe Hemorrhagic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 52 Europe Stroke Market, By Diagnosis And Treatment, 2018-2032 (Usd Thousand)
- Table 53 Europe Treatment In Stroke Market, By Treatment Type, 2018-2032 (Usd Thousand)
- Table 54 Europe Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)..
- Table 55 Europe Blood Pressure Medicine In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 56 Europe Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 57 Europe Thiazide Diuretics In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 58 Europe Calcium Channel Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 59 Europe Beta Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 60 Europe Alpha-blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 61 Europe Antiplatelet Drugs In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 62 Europe Anticoagulants In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 63 Europe Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 64 Europe Statins In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 65 Europe Supportive Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 66 Europe Medication In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)
- Table 67 Europe Branded In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)
- Table 68 Europe Medication In Stroke Market, By Route Of Administration, 2018-2032 (Usd Thousand)
- Table 69 Europe Oral In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 70 Europe Parenteral In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 71 Europe Medication In Stroke Market, By Mode Of Purchase, 2018-2032 (Usd Thousand)
- Table 72 Europe Medication In Stroke Market, By Therapy Type, 2018-2032 (Usd Thousand)
- Table 73 Europe Surgery In Stroke Market, By Instrument Type, 2018-2032 (Usd Thousand)
- Table 74 Europe Other Therapy In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 75 Europe Diagnosis In Stroke Market, By Diagnosis Type, 2018-2032 (Usd Thousand)
- Table 76 Europe Imaging Test In Stroke Market, By Type, 2018-2032 (Usd Thousand)..
- Table 77 Europe Stroke Market, By Gender, 2018-2032 (Usd Thousand)
- Table 78 Europe Stroke Market, By End User, 2018-2032 (Usd Thousand)
- Table 79 Europe Stroke Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 80 Germany Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 81 Germany Ischemic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 82 Germany Hemorrhagic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 83 Germany Stroke Market, By Diagnosis And Treatment, 2018-2032 (Usd Thousand)
- Table 84 Germany Treatment In Stroke Market, By Treatment Type, 2018-2032 (Usd Thousand)
- Table 85 Germany Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 86 Germany Blood Pressure Medicine In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 87 Germany Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 88 Germany Thiazide Diuretics In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 89 Germany Calcium Channel Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 90 Germany Beta Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 91 Germany Alpha-blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 92 Germany Antiplatelet Drugs In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 93 Germany Anticoagulants In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 94 Germany Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 95 Germany Statins In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 96 Germany Supportive Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 97 Germany Medication In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)
- Table 98 Germany Branded In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)
- Table 99 Germany Medication In Stroke Market, By Route Of Administration, 2018-2032 (Usd Thousand)
- Table 100 Germany Oral In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 101 Germany Parenteral In Stroke Market, By Type, 2018-2032 (Usd Thousand)..
- Table 102 Germany Medication In Stroke Market, By Mode Of Purchase, 2018-2032 (Usd Thousand)
- Table 103 Germany Medication In Stroke Market, By Therapy Type, 2018-2032 (Usd Thousand)
- Table 104 Germany Surgery In Stroke Market, By Instrument Type, 2018-2032 (Usd Thousand)
- Table 105 Germany Other Therapy In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 106 Germany Diagnosis In Stroke Market, By Diagnosis Type, 2018-2032 (Usd Thousand)
- Table 107 Germany Imaging Test In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 108 Germany Stroke Market, By Gender, 2018-2032 (Usd Thousand)
- Table 109 Germany Stroke Market, By End User, 2018-2032 (Usd Thousand)
- Table 110 Germany Stroke Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 111 U.K. Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 112 U.K. Ischemic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)..
- Table 113 U.K. Hemorrhagic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 114 U.K. Stroke Market, By Diagnosis And Treatment, 2018-2032 (Usd Thousand)
- Table 115 U.K. Treatment In Stroke Market, By Treatment Type, 2018-2032 (Usd Thousand)
- Table 116 U.K. Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 117 U.K. Blood Pressure Medicine In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 118 U.K. Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 119 U.K. Thiazide Diuretics In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 120 U.K. Calcium Channel Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 121 U.K. Beta Blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)…
- Table 122 U.K. Alpha-blockers In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 123 U.K. Antiplatelet Drugs In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 124 U.K. Anticoagulants In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 125 U.K. Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 126 U.K. Statins In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 127 U.K. Supportive Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 128 U.K. Medication In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)..
- Table 129 U.K. Branded In Stroke Market, By Drug Type, 2018-2032 (Usd Thousand)
- Table 130 U.K. Medication In Stroke Market, By Route Of Administration, 2018-2032 (Usd Thousand)
- Table 131 U.K. Oral In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 132 U.K. Parenteral In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 133 U.K. Medication In Stroke Market, By Mode Of Purchase, 2018-2032 (Usd Thousand)
- Table 134 U.K. Medication In Stroke Market, By Therapy Type, 2018-2032 (Usd Thousand)
- Table 135 U.K. Surgery In Stroke Market, By Instrument Type, 2018-2032 (Usd Thousand)
- Table 136 U.K. Other Therapy In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 137 U.K. Diagnosis In Stroke Market, By Diagnosis Type, 2018-2032 (Usd Thousand)
- Table 138 U.K. Imaging Test In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 139 U.K. Stroke Market, By Gender, 2018-2032 (Usd Thousand)
- Table 140 U.K. Stroke Market, By End User, 2018-2032 (Usd Thousand)
- Table 141 U.K. Stroke Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 142 France Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 143 France Ischemic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 144 France Hemorrhagic Stroke In Stroke Market, By Type, 2018-2032 (Usd Thousand)
- Table 145 France Stroke Market, By Diagnosis And Treatment, 2018-2032 (Usd Thousand)
- Table 146 France Treatment In Stroke Market, By Treatment Type, 2018-2032 (Usd Thousand)
- Table 147 France Medication In Stroke Market, By Class, 2018-2032 (Usd Thousand)…
- Table 148 France Blood Pressure Medicine In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- Table 149 France Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2018-2032 (Usd Thousand)
- List Of Figures
- Figure 1 Europe Stroke Market: Segmentation
- Figure 2 Europe Stroke Market: Data Triangulation
- Figure 3 Europe Stroke Market: Droc Analysis
- Figure 4 Europe Stroke Market : Europe Vs Regional Market Analysis
- Figure 5 Europe Stroke Market: Company Research Analysis
- Figure 6 Europe Stroke Market: Interview Demographics
- Figure 7 Europe Stroke Market: Dbmr Market Position Grid
- Figure 8 Europe Stroke Market: Market End User Coverage Grid
- Figure 9 Europe Stroke Market: Vendor Share Analysis
- Figure 10 Europe Stroke Market: Segmentation
- Figure 11 Rising Incidences Of Stroke Drive Demand For Treatments Is Expected To Drive The Europe Stroke Market Growth In The Forecast Period Of 2025 To 2032
- Figure 12 Ischemic Stroke Segment Is Expected To Account For The Largest Share Of The Europe Stroke Market In The Forecast Period Of 2025 & 2032
- Figure 13 Europe Stroke Market Executive Summary
- Figure 14 Strategic Decisions
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Europe Stroke Market
- Figure 16 Europe Stroke Market: By Type, 2024
- Figure 17 Europe Stroke Market: By Type, 2025-2032 (Usd Thousand)
- Figure 18 Europe Stroke Market: By Type, Cagr (2025-2032)
- Figure 19 Europe Stroke Market: By Type, Lifeline Curve
- Figure 20 Europe Stroke Market: By Gender, 2024
- Figure 21 Europe Stroke Market: By Gender, 2025 To 2032 (Usd Thousand)
- Figure 22 Europe Stroke Market: By Gender, Cagr (2025- 2032)
- Figure 23 Europe Stroke Market: By Gender, Lifeline Curve
- Figure 24 Europe Stroke Market: By Diagnosis And Treatment, 2024
- Figure 25 Europe Stroke Market: By Diagnosis And Treatment, 2025-2032 (Usd Thousand)
- Figure 26 Europe Stroke Market: By Diagnosis And Treatment, Cagr (2025-2032)
- Figure 27 Europe Stroke Market: By Diagnosis And Treatment, Lifeline Curve
- Figure 28 Europe Stroke Market: By Distribution Channel, 2024
- Figure 29 Europe Stroke Market: By Distribution Channel, 2018-2032 (Usd Thousand)
- Figure 30 Europe Stroke Market: By Distribution Channel, Cagr (2025-2032)
- Figure 31 Europe Stroke Market: By Distribution Channel, Lifeline Curve
- Figure 32 Europe Stroke Market: By End User, 2024
- Figure 33 Europe Stroke Market: By End User, 2025-2032 (Usd Thousand)
- Figure 34 Europe Stroke Market: By End User, Cagr (2025-2032)
- Figure 35 Europe Stroke Market: By End User, Lifeline Curve
- Figure 36 Europe Stroke Market: Snapshot (2024)
- Figure 37 Europe Stroke Market: Company Share 2024 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
